We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advises Melamine Tests for At-Risk Components
FDA Advises Melamine Tests for At-Risk Components
August 7, 2009
Drugmakers should determine if they are using components possibly contaminated with melamine and test those found at risk, as well as make sure they get certifications from suppliers that at-risk components have been tested appropriately.